EPIGENETIC AGING OF THE OXIDATIVE STRESS RESPONSE IN THE MOUSE RPE

小鼠 RPE 氧化应激反应的表观遗传老化

基本信息

项目摘要

DESCRIPTION (provided by applicant): Aging is the largest single risk factor for the development of complex genetic disease including cancer, autoimmune disease, and neurodegeneration (including age-related macular degeneration - AMD). The primary theory attempting to explain the role of aging in these diseases is focused on the macromolecular damage caused by reactive oxygen species (ROS) and the genetics of susceptibility to this damage. Complex genetic disease however can also be investigated from the perspective of epigenetics. Gene expression for many genes is epigenetically regulated as a function of age, and altered expression of these genes is potentially linked to the development and progression of disease. We hypothesize that age-related change in the expression of oxidative stress genes are the result of epigenetic changes in cytosine methylation in genomic DNA in the retinal pigment epithelium (RPE)/choroid. This type of methylation is the most common epigenetic modification of the genome. We will first measure the age-related change of the expression and cytosine methylation of a set of candidate genes in the mouse RPE/choroid which are linked to oxidative stress. The set includes Er1, Err1, Foxo3a, Nrf2, Pgc11, Prdx3, p66/Shc1, Sirt1, Sod2, Txn2, Txnrd2, and 14-3-38. Our preliminary data indicate that Prdx3, Sod2, and Txn2 may be epigenetically upregulated as a function of age. Next we will validate these results for SOD2 in the human RPE using fresh frozen and/or paraffin embedded tissue. The significance of this work is the development of a new approach to understanding the age-related risk for complex genetic disease in the retinal pigment epithelium. This approach will yield new targets for drug development and potential treatments which may enhance our current management of age-related macular degeneration (AMD). PUBLIC HEALTH RELEVANCE: This proposal outlines research on the epigenetics of age-related changes in the oxidative stress response in the mouse and human retinal pigment epithelium. The goal is to identify genes that may also be epigenetically regulated in human age-related retinal degeneration. The significance of this work is to provide a deeper understanding of how age is related to retinal degeneration, and the identification of new targets for drug development. This work will eventually lead to the development of individualized treatments for blinding eye diseases.
描述(由申请人提供):衰老是发展复杂遗传疾病的最大单一风险因素,包括癌症、自身免疫性疾病和神经变性(包括年龄相关性黄斑变性- AMD)。试图解释衰老在这些疾病中的作用的主要理论集中在由活性氧(ROS)引起的大分子损伤和对这种损伤易感性的遗传学上。然而,复杂的遗传疾病也可以从表观遗传学的角度进行研究。许多基因的基因表达是作为年龄的函数进行表观遗传调节的,并且这些基因的改变的表达可能与疾病的发展和进展相关。我们推测,氧化应激基因表达的年龄相关变化是视网膜色素上皮(RPE)/脉络膜中基因组DNA胞嘧啶甲基化的表观遗传变化的结果。这种类型的甲基化是基因组最常见的表观遗传修饰。我们将首先测量小鼠RPE/脉络膜中与氧化应激相关的一组候选基因的表达和胞嘧啶甲基化的年龄相关变化。该组包括Er 1、Err 1、Foxo 3a、Nrf 2、Pgc 11、Prdx 3、p66/Shc 1、Sirt 1、Sod 2、Txn 2、Txnrd 2和14-3-38。我们的初步数据表明,Prdx 3,Sod 2和Txn 2可能作为年龄的函数在表观遗传学上上调。接下来,我们将使用新鲜冷冻和/或石蜡包埋的组织验证人RPE中SOD 2的这些结果。这项工作的意义在于开发了一种新的方法来了解视网膜色素上皮中复杂遗传疾病的年龄相关风险。这种方法将为药物开发和潜在治疗提供新的靶点,这可能会增强我们目前对年龄相关性黄斑变性(AMD)的管理。 公共卫生关系:该提案概述了小鼠和人类视网膜色素上皮细胞氧化应激反应中与年龄相关变化的表观遗传学研究。目标是确定在人类年龄相关性视网膜变性中也可能受到表观遗传调控的基因。这项工作的意义在于更深入地了解年龄与视网膜变性的关系,并确定药物开发的新靶点。这项工作将最终导致失明眼病的个体化治疗的发展。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Potential therapeutic approaches for modulating expression and accumulation of defective lamin A in laminopathies and age-related diseases.
  • DOI:
    10.1007/s00109-012-0962-4
  • 发表时间:
    2012-12
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
    Zhavoronkov, Alex;Smit-McBride, Zeljka;Guinan, Kieran J.;Litovchenko, Maria;Moskalev, Alexey
  • 通讯作者:
    Moskalev, Alexey
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Leonard Martin Hjelmeland其他文献

Leonard Martin Hjelmeland的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Leonard Martin Hjelmeland', 18)}}的其他基金

Epigenetic regulation of SOD2 and CFH gene expression in the aging RPE
衰老 RPE 中 SOD2 和 CFH 基因表达的表观遗传调控
  • 批准号:
    8538398
  • 财政年份:
    2011
  • 资助金额:
    $ 61.75万
  • 项目类别:
Epigenetic regulation of SOD2 and CFH gene expression in the aging RPE
衰老 RPE 中 SOD2 和 CFH 基因表达的表观遗传调控
  • 批准号:
    8328681
  • 财政年份:
    2011
  • 资助金额:
    $ 61.75万
  • 项目类别:
Epigenetic regulation of SOD2 and CFH gene expression in the aging RPE
衰老 RPE 中 SOD2 和 CFH 基因表达的表观遗传调控
  • 批准号:
    8085950
  • 财政年份:
    2011
  • 资助金额:
    $ 61.75万
  • 项目类别:
Age-related epigenetic gene silencing in the RPE
RPE 中与年龄相关的表观遗传基因沉默
  • 批准号:
    7138505
  • 财政年份:
    2006
  • 资助金额:
    $ 61.75万
  • 项目类别:
Age-related epigenetic gene silencing in the RPE
RPE 中与年龄相关的表观遗传基因沉默
  • 批准号:
    7270099
  • 财政年份:
    2006
  • 资助金额:
    $ 61.75万
  • 项目类别:
REDOX CONTROL OF FGF GENE EXPRESSION IN AGING RPE
衰老 RPE 中 FGF 基因表达的氧化还原控制
  • 批准号:
    6384530
  • 财政年份:
    1986
  • 资助金额:
    $ 61.75万
  • 项目类别:
BIOCHEMICAL MODULATION OF RETINAL GLIOSIS
视网膜胶质细胞增生的生化调节
  • 批准号:
    3262655
  • 财政年份:
    1986
  • 资助金额:
    $ 61.75万
  • 项目类别:
BIOCHEMICAL MODULATION OF RETINAL GLIOSIS
视网膜胶质细胞增生的生化调节
  • 批准号:
    3262656
  • 财政年份:
    1986
  • 资助金额:
    $ 61.75万
  • 项目类别:
REGULATION OF FGF EXPRESSION DURING RETINAL DETACHMENT
视网膜脱离过程中 FGF 表达的调节
  • 批准号:
    3262654
  • 财政年份:
    1986
  • 资助金额:
    $ 61.75万
  • 项目类别:
REGULATION OF FGF EXPRESSION DURING RETINAL DETACHMENT
视网膜脱离过程中 FGF 表达的调节
  • 批准号:
    2710920
  • 财政年份:
    1986
  • 资助金额:
    $ 61.75万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 61.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 61.75万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 61.75万
  • 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 61.75万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 61.75万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 61.75万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 61.75万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 61.75万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 61.75万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 61.75万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了